Search results

Page results

• Wearable tech, AI and clinical teams combine to change the face of clinical trial monitoring

  A multi-disciplinary team involving UCLH and UCL has developed a way to monitor the progression of movement disorders using motion capture technology and AI.

• First UK proton beam therapy trial for breast cancer launches at UCLH

  The first UK trial to test the benefits of proton beam therapy for certain patients with breast cancer has launched at UCLH.

• Milestone of 1000 robotic operations reached

  The UCLH trauma and orthopaedics team has reached a milestone of 1000 operations on hips and knees using the Mako robot.

• Recruitment milestone reached in large breast cancer trial

  3000 participants have been recruited to a clinical trial led by UCL and UCLH aimed at reducing the number of patients with breast cancer who are given chemotherapy unnecessarily.

• UCLH doctor 1 of 10 international members elected to National Academy of Medicine

  UCLH doctor 1 of 10 international members elected to National Academy of Medicine

• Professor Mark Emberton, non-executive director

  Mark Emberton joined the board as a non-executive director on 1 September 2022. He is Professor of Intervention Oncology within the Division of Surgery and Dean of the Faculty of Medical Science at University College London. 

• Immunomodulatory drug for COVID-19 trialled at UCLH

  UCLH is contributing to a national priority trial of the drug ruxolitinib in patients with Covid-19 pneumonia (infection of the lungs).

• More than 100 pieces of art in UCLH’s Grafton Way Building

  UCLH is committed to not only treat patients’ illnesses but to provide an environment and an experience which contributes to patients’ general wellbeing.

• Supporting young people with sickle cell at Tottenham Hotspur

  On Saturday 25 June 2022, UCLH partnered with North Middlesex University Hospital and Whittington Health to run a summer sickle cell event at Tottenham Hotspur Stadium for children and young people with sickle cell disorder.

• Research into restoring loss of smell and taste in COVID patients

  Specialist teams at UCLH and UCL are at the forefront of research which could bring hope to people who have been robbed of their sense of smell and taste after suffering the long-term legacy of COVID-19.